Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03329924 · ClinicalTrials.gov registry record
ICU Liberation: Does Enhanced Patient Mobilization Improve Outcomes?
A clinical trial, sponsored by Bassett Healthcare.
- Completed
- Registry status
- 220
- Enrollment target
NCT03329924: Completed study, sponsored by Bassett Healthcare.
NCT03329924 is a clinical trial that has completed, run by Bassett Healthcare. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03329924 has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
The hypothesis of this study is that an early mobilization program coupled with organizational efforts to implement the ABCDEF bundle will increase the rate of ICU patient mobilization and decrease the ICU length of stay, but will not significantly affect patient mortality. Mobilization efforts will be done to improve patient care and the study will allow for measurement of the effects of implementation of this effort. The early mobilization program is being instituted as standard of care. The study will measure the actual degree of change in patients' activity level and to evaluate the effect of the program on outcome measures such as length of stay.
Primary Outcome
activity level during a patient's ICU admission will be measured by accelerometer
Interventions
- OTHER Activity level measurement by accelerometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2023-01-01 |
What the finished NCT03329924 record still lists
NCT03329924 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Activity level measurement by accelerometer is the first listed.
NCT03329924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03329924 about?
NCT03329924 is a clinical study titled "ICU Liberation: Does Enhanced Patient Mobilization Improve Outcomes?". The hypothesis of this study is that an early mobilization program coupled with organizational efforts to implement the ABCDEF bundle will increase the rate of ICU patient mobilization and decrease the ICU length of stay, but will not significantly affect patient mortality. Mobilization efforts will...
What is the current status of trial NCT03329924?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2017-12-01. Estimated completion is 2023-01-01.
What interventions are being tested in trial NCT03329924?
The interventions under investigation include: Activity level measurement by accelerometer (OTHER).
Who is sponsoring clinical trial NCT03329924?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI